Drug
Suvecaltamide clinical trials
Also written CX-8998 and JZP385.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Name
Studies by the year they started
6 studies that test it; most in 2009 (1)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Studies
Open first, then newest update. How each study uses suvecaltamide is read from its arms, and is right about nine times in ten.
Testing it · 6
- A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's DiseaseCompletedPhase 2Jazz PharmaceuticalsNCT05642442Written as Suvecaltamide
- A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET)CompletedPhase 2Jazz PharmaceuticalsNCT05122650Written as JZP385
- CX-8998 for Absence SeizuresCompletedPhase 2Jazz PharmaceuticalsNCT03406702Written as CX-8998
- A Phase 2 RCT Study of CX-8998 for Essential TremorCompletedPhase 2Jazz PharmaceuticalsNCT03101241Written as CX-8998
- A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's DiseaseWithdrawnPhase 2Jazz PharmaceuticalsNCT03436953Written as CX-8998
- A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)CompletedPhase 2Merck Sharp & Dohme LLCNCT00827918Written as MK-8998
Codes
What other systems call suvecaltamide · ClinicalTrials.gg INT017301
- UNII (FDA) MIA4WMP8QNSUVECALTAMIDEOne source FDA
- NCI Thesaurus C174710SuvecaltamideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | MIA4WMP8QN | SUVECALTAMIDE | One source FDA |
| NCI Thesaurus | C174710 | Suvecaltamide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.